Medical Condition News

RSS

DePuy Orthopaedics announces voluntary recall of ASR XL Acetabular and Hip Resurfacing systems

DePuy Orthopaedics, Inc., announced it is voluntarily recalling the ASR™ XL Acetabular System and DePuy ASR™ Hip Resurfacing System used in hip replacement surgery due to the number of patients who required a second hip replacement procedure, called a revision surgery.

26 Aug 2010

Dose-defining Phase IIa trial of CXL-1020 initiated for treating patients with ADHF

Cardioxyl Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing therapeutic agents for the treatment of cardiovascular disease, today announced that it has initiated a dose-defining Phase IIa trial of its lead drug candidate, CXL-1020, for the treatment of patients with acute decompensated heart failure.

26 Aug 2010

23rd European College of Neuropsychopharmacology Congress to be held 28 Aug - 1 Sep 2010 in Amsterdam

Mental disorders, such as depression, anxiety disorders, addiction and schizophrenia are the core challenge of most health care systems around the world. In the EU alone, each year 27% of the total adult population - this corresponds to 83 Million citizens - suffer from mental disorders. Depression alone affects almost 20 million ranking in the EU as the most disabling disorder of all diseases.

26 Aug 2010

YFALS Campaign to appear in Milwaukee, Atlanta and Seattle

The Young Faces of ALS Campaign raises awareness of ALS and those diagnosed with the progressive neurodegenerative disease at a young age. Starting today, the campaign will make stops at Major League Baseball ballparks in Milwaukee, Atlanta and Seattle.

26 Aug 2010

FDA approves Chelsea Therapeutics' Phase II protocol for CH-4051 antifolate in rheumatoid arthritis

Chelsea Therapeutics International, Ltd. announced confirmation by the U.S. Food and Drug Administration (FDA) that its proposed Phase II protocol for CH-4051 in rheumatoid arthritis has been approved by the agency.

26 Aug 2010

FDA notification confirms acyclovir Lauriad for oro-facial herpes labialis

BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, today announces that the US Food and Drug Administration (FDA) considers the positive results of the pivotal phase III study with acyclovir Lauriad acceptable to submit a 505(b)(2) New Drug Application of the product in the United States.

26 Aug 2010

SOECIC announces UK's first operation to fit single cochlear implant to give sound in both ears

The UK's first operation to fit a single cochlear implant capable of giving sound in both ears takes place this Friday (27 August), thanks to the work of the South of England Cochlear Implant Centre (SOECIC), based at the University of Southampton.

26 Aug 2010

Octapharma completes clinical development of Uniplas human pooled plasma

Octapharma AG, one of the largest private manufacturers of plasma products in the world, announced today that the clinical development for Uniplas® has been successfully completed. The product has been filed for registration in Europe and will be submitted later in the USA.

26 Aug 2010

Tree Top enters Letter of Intent with WorldWithoutBlindness

Recently Tree Top, entered into a Letter of Intent with WorldWithoutBlindness, LLC, ("WWB"), a not-for-profit medical corporation whose expressed mission is "to prevent blindness through screening and early disease detection, patient information, physician education and vision science research." During due diligence, Tree Top's management, along with WWB related medical staff, identified that more work needed to be done to successfully implement WWB's business model.

26 Aug 2010

Psychiatric Foundation program recognizes PSE as innovator for addressing cognitive, behavioral disabilities

The Partnership for Workplace Mental Health this month recognized Puget Sound Energy as an innovator for the utility's disability case management approach to address the effects of psychiatric and cognitive functioning issues on employee behavior and work performance.

26 Aug 2010

Motor proteins play critical role in stabilization of long-term memories

Functioning much like gears in a machine, cellular motor proteins are critical to dynamic functions throughout the body, including muscle contraction, cell migration and cellular growth processes. Now, neuroscientists from UC Irvine and the Florida campus of The Scripps Research Institute report that motor proteins also play a critical role in the stabilization of long-term memories. The findings add an unexpected dimension to the story of how memories are encoded and suggest new targets for therapeutic interventions.

26 Aug 2010

Saint Thomas Health Services to offer program for neurosurgical patients’ better care

August is Neurosurgery Outreach Month, an effort to increase the public's knowledge about the powerful effects of neurosurgery, many of which are taking place at Saint Thomas Health Services in Tennessee.

26 Aug 2010

Data from PLX4032 Phase 1 clinical trial in melanoma patients with BRAF mutation published

Plexxikon today announced publication of data from the Phase 1 clinical trial of PLX4032 (RG7204), confirming that treatment of metastatic melanoma patients with the BRAF V600E mutation resulted in significant tumor shrinkage in the majority of patients. Specifically, in the melanoma extension cohort of the study, nearly all patients showed some response; 81 percent of patients had tumor shrinkage of at least 30 percent.

26 Aug 2010

Treating metastatic melanoma tumors with specific genetic signature shows promising results

Use of an experimental targeted drug to treat metastatic melanoma tumors with a specific genetic signature was successful in more than 80 percent of patients in a phase 1 clinical trial.

26 Aug 2010

Panasonic introduces digital hearing instruments in U.S. market

Panasonic Corporation of North America, today announced that Panasonic Hearing instruments have been delivered to the U.S. market. The company is debuting three types of digital hearing instruments, including a new form factor that resembles the style of an MP3 player, a receiver-in-canal and behind-the-ear models. Panasonic is currently establishing a distribution network throughout the U.S.

From PHC Europe B.V. 26 Aug 2010

PLX4032 therapy results in tumor shrinkage in metastatic melanoma patients

A multicenter study has concluded that treatment with a new targeted therapy called PLX4032 (also called RG7204) resulted in significant tumor shrinkage in 80 percent of patients with advanced melanoma.

26 Aug 2010

UNC Hospitals receives NCDR ACTION Registry-GWTG Silver Performance Achievement Award

UNC Hospitals has received the American College of Cardiology Foundation's NCDR ACTION Registry-GWTG Silver Performance Achievement Award for 2010 - one of only 26 hospitals nationwide to do so.

26 Aug 2010

Biomoda's CyPath assay for lung cancer detection receives Canadian patent

Cancer diagnostics company Biomoda, Inc. has received a notice of allowance for a Canadian patent application for a method of using its proprietary porphyrin-based compound that binds to cancer cells and causes them to fluoresce under specific frequencies of light when viewed under a fluorescent microscope.

26 Aug 2010

Critical mechanistic link between mutant protein and disease pathogenesis in ALS uncovered

New research uncovers what may be a primary neuron-damaging insult that occurs in an inherited form of a devastating neurodegenerative disorder. The study, published by Cell Press in the August 26th issue of the journal Neuron, describes a critical mechanistic link between a mutant protein and disease pathogenesis in an animal model of amyotrophic lateral sclerosis (ALS).

26 Aug 2010

Researchers develop microneedles to deliver quantum dots for skin cancer treatment

Researchers from North Carolina State University have developed extremely small microneedles that can be used to deliver medically-relevant nanoscale dyes called quantum dots into skin - an advance that opens the door to new techniques for diagnosing and treating a variety of medical conditions, including skin cancer.

26 Aug 2010

Medical Condition News

DePuy Orthopaedics announces voluntary recall of ASR XL Acetabular and Hip Resurfacing systems

Dose-defining Phase IIa trial of CXL-1020 initiated for treating patients with ADHF

23rd European College of Neuropsychopharmacology Congress to be held 28 Aug - 1 Sep 2010 in Amsterdam

YFALS Campaign to appear in Milwaukee, Atlanta and Seattle

FDA approves Chelsea Therapeutics' Phase II protocol for CH-4051 antifolate in rheumatoid arthritis

FDA notification confirms acyclovir Lauriad for oro-facial herpes labialis

SOECIC announces UK's first operation to fit single cochlear implant to give sound in both ears

Octapharma completes clinical development of Uniplas human pooled plasma

Tree Top enters Letter of Intent with WorldWithoutBlindness

Psychiatric Foundation program recognizes PSE as innovator for addressing cognitive, behavioral disabilities

Motor proteins play critical role in stabilization of long-term memories

Saint Thomas Health Services to offer program for neurosurgical patients’ better care

Data from PLX4032 Phase 1 clinical trial in melanoma patients with BRAF mutation published

Treating metastatic melanoma tumors with specific genetic signature shows promising results

Panasonic introduces digital hearing instruments in U.S. market

PLX4032 therapy results in tumor shrinkage in metastatic melanoma patients

UNC Hospitals receives NCDR ACTION Registry-GWTG Silver Performance Achievement Award

Biomoda's CyPath assay for lung cancer detection receives Canadian patent

Critical mechanistic link between mutant protein and disease pathogenesis in ALS uncovered

Researchers develop microneedles to deliver quantum dots for skin cancer treatment

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News